102 related articles for article (PubMed ID: 23136069)
1. Antinociceptive profile of potent opioid peptide AM94, a fluorinated analogue of biphalin with non-hydrazine linker.
Mollica A; Costante R; Stefanucci A; Pinnen F; Lucente G; Fidanza S; Pieretti S
J Pept Sci; 2013 Apr; 19(4):233-9. PubMed ID: 23136069
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive profile of biphalin, a dimeric enkephalin analog.
Horan PJ; Mattia A; Bilsky EJ; Weber S; Davis TP; Yamamura HI; Malatynska E; Appleyard SM; Slaninova J; Misicka A
J Pharmacol Exp Ther; 1993 Jun; 265(3):1446-54. PubMed ID: 8389867
[TBL] [Abstract][Full Text] [Related]
3. Potent biphalin analogs with µ/δ mixed opioid activity: in vivo and in vitro biological evaluation.
Costante R; Pinnen F; Stefanucci A; Mollica A
Arch Pharm (Weinheim); 2014 May; 347(5):305-12. PubMed ID: 24798820
[TBL] [Abstract][Full Text] [Related]
4. The analgesic activity of biphalin and its analog AM 94 in rats.
Leone S; Chiavaroli A; Orlando G; Mollica A; Di Nisio C; Brunetti L; Vacca M
Eur J Pharmacol; 2012 Jun; 685(1-3):70-3. PubMed ID: 22546229
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal antinociceptive interaction between the NMDA antagonist ketamine and the opioids, morphine and biphalin.
Kosson D; Klinowiecka A; Kosson P; Bonney I; Carr DB; Mayzner-Zawadzka E; Lipkowski AW
Eur J Pain; 2008 Jul; 12(5):611-6. PubMed ID: 18068383
[TBL] [Abstract][Full Text] [Related]
6. Biphalin analogs containing β(3)-homo-amino acids at the 4,4' positions: Synthesis and opioid activity profiles.
Frączak O; Lasota A; Kosson P; Leśniak A; Muchowska A; Lipkowski AW; Olma A
Peptides; 2015 Apr; 66():13-8. PubMed ID: 25708417
[TBL] [Abstract][Full Text] [Related]
7. Design of Analgesic Trivalent Peptides with Low Withdrawal Symptoms: Probing the Antinociceptive Profile of Novel Linear and Cyclic Peptides as Opioid Pan Ligands.
Stefanucci A; Minosi P; Pieretti S; Tanguturi P; Molnar G; Scioli G; Marinaccio L; Della Valle A; Streicher JM; Mollica A
ACS Chem Neurosci; 2023 Feb; 14(3):506-515. PubMed ID: 36651179
[TBL] [Abstract][Full Text] [Related]
8. Enkephalin derivative, cyclo[Nepsilon,Nbeta-carbonyl-D-Lys2, Dap5] enkephalinamide (cUENK6), induces a highly potent antinociception in rats.
Kotlinska J; Bochenski M; Lagowska-Lenard M; Gibula-Bruzda E; Witkowska E; Izdebski J
Neuropeptides; 2009 Jun; 43(3):221-8. PubMed ID: 19376576
[TBL] [Abstract][Full Text] [Related]
9. Biological properties of a new fluorescent biphalin fragment analogue.
Lipkowski AW; Misicka A; Kosson D; Kosson P; Lachwa-From M; Brodzik-Bienkowska A; Hruby VJ
Life Sci; 2002 Jan; 70(8):893-7. PubMed ID: 11853227
[TBL] [Abstract][Full Text] [Related]
10. Brain and spinal cord distribution of biphalin: correlation with opioid receptor density and mechanism of CNS entry.
Abbruscato TJ; Thomas SA; Hruby VJ; Davis TP
J Neurochem; 1997 Sep; 69(3):1236-45. PubMed ID: 9282948
[TBL] [Abstract][Full Text] [Related]
11. The biological consequences of replacing D-Ala in biphalin with amphiphilic α-alkylserines.
Frączak O; Lasota A; Leśniak A; Lipkowski AW; Olma A
Chem Biol Drug Des; 2014 Aug; 84(2):199-205. PubMed ID: 24674466
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological properties of a new fluorescent opioid peptide analog.
Lukowiak M; Kosson P; Hennink WE; Lipkowski AW
Pharmacol Rep; 2009; 61(4):727-31. PubMed ID: 19815956
[TBL] [Abstract][Full Text] [Related]
13. Biphalin, an enkephalin analog with unexpectedly high antinociceptive potency and low dependence liability in vivo, selectively antagonizes excitatory opioid receptor functions of sensory neurons in culture.
Shen KF; Crain SM
Brain Res; 1995 Dec; 701(1-2):158-66. PubMed ID: 8925279
[TBL] [Abstract][Full Text] [Related]
14. Blood-to-central nervous system entry and stability of biphalin, a unique double-enkephalin analog, and its halogenated derivatives.
Abbruscato TJ; Williams SA; Misicka A; Lipkowski AW; Hruby VJ; Davis TP
J Pharmacol Exp Ther; 1996 Mar; 276(3):1049-57. PubMed ID: 8786534
[TBL] [Abstract][Full Text] [Related]
15. Biphalin preferentially recruits peripheral opioid receptors to facilitate analgesia in a mouse model of cancer pain - A comparison with morphine.
Lesniak A; Bochynska-Czyz M; Sacharczuk M; Benhye S; Misicka A; Bujalska-Zadrozny M; Lipkowski AW
Eur J Pharm Sci; 2016 Jun; 89():39-49. PubMed ID: 27094782
[TBL] [Abstract][Full Text] [Related]
16. Conjugation of low molecular weight poly(ethylene glycol) to biphalin enhances antinociceptive profile.
Huber JD; Campos CR; Egleton RD; Witt K; Guo L; Roberts MJ; Bentley MD; Davis TP
J Pharm Sci; 2003 Jul; 92(7):1377-85. PubMed ID: 12820142
[TBL] [Abstract][Full Text] [Related]
17. Biphalin-A Potent Opioid Agonist-As a Panacea for Opioid System-Dependent Pathophysiological Diseases?
Redkiewicz P; Dyniewicz J; Misicka A
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768778
[TBL] [Abstract][Full Text] [Related]
18. Delta opioid receptors contribute to the cardiorespiratory effects of biphalin in anesthetized rats.
Wojciechowski P; Szereda-Przestaszewska M; Lipkowski AW
Pharmacol Rep; 2011; 63(5):1235-42. PubMed ID: 22180367
[TBL] [Abstract][Full Text] [Related]
19. Analgesic activity of a novel bivalent opioid peptide compared to morphine via different routes of administration.
Silbert BS; Lipkowski AW; Cepeda MS; Szyfelbein SK; Osgood PF; Carr DB
Agents Actions; 1991 Jul; 33(3-4):382-7. PubMed ID: 1950824
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of biphalin analogs and their biological evaluation on opioid receptors.
Feliciani F; Pinnen F; Stefanucci A; Costante R; Cacciatore I; Lucente G; Mollica A
Mini Rev Med Chem; 2013 Jan; 13(1):11-33. PubMed ID: 22512573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]